微波加清喉利咽颗粒治疗慢性肥厚性咽炎(1)
 |
| 第1页 |
参见附件(2167KB，2页)。
[摘要] 目的：探讨治疗慢性肥厚性咽炎的有效方法。方法：将慢性肥厚性咽炎540例随机分为3组，治疗组采用微波治疗，结合术后口服清喉利咽颗粒，每次1袋，每日3次，共2周；对照组Ⅰ单纯口服清喉利咽颗粒，每次1袋，每日3次，共2周；对照组Ⅱ单纯采用微波治疗。结果：治疗组总有效率为95.6%(172/180)，对照组Ⅰ总有效率为66.1%(119/180)，对照组Ⅱ总有效率为60.6%(109/180)，治疗组与2个对照组比较，差异均有统计学意义(均P<0.05)，明显高于2个对照组。结论：微波加清喉利咽颗粒治疗慢性肥厚性咽炎可以获得明显的治疗效果，具有较好的临床价值。
[关键词] 咽炎；微波；清喉利咽颗粒
[中图分类号] R766.14[文献标识码]B[文章编号]1673-7210(2011)04(a)-175-02
Treating chronic hypertrophic pharyngitis by microwave combined with Qinghouliyan granules
LU Huaigang1，ZHANG Yan2
1.Yantai Nursing School, Yantai City, Shandong Province, Yantai 264000, China; 2.Yuhuangding Hospital of Yantai City, Shandong province, Yantai 264000, China
[Abstract] Objective: To probe into one effective therapy to cure chronic hypertrophic pharyngitis. Methods: 540 cases with chronic hypertrophic pharyngitis were randomly divided into three groups, 180 cases in treatment group treated by the combined therapy with microwave followed by Qinghouliyan granules taked for 2 weeks, and 180 cases in control groupⅠtreated simply by Qinghouliyan granules, and 180 cases in control groupⅡ treated simply by microwave. Results: The total effective rate of the treatment group and the other two control groups were 95.6%(172/180), 66.1%(119/180) and 60.6%(109/180) respectively. There were significant differences of the therapeutic effect between the treatment group and the two control groups respectively(all P<0.05), with the total effective rate of the treatment group being higher than other two control groups. Conclusion: The combined therapy with microwave followed by Qinghouliyan granules is very effective for the treatment of chronic hypertrophic pharyngitis.
[Key words] Pharyngitis; Microwave; Qinghouliyan granules
慢性肥厚性咽炎是耳鼻咽喉科常见病、多发病，是以咽黏膜、黏膜下及淋巴组织增生为主要表现的慢性炎症。本病常发生于成人，病程长，症状反复，不易消除，治疗方法很多，但疗效不满意。本文对我校门诊540例慢性肥厚性咽炎患者采用微波和(或)清喉利咽颗粒治疗，效果显著，分析如下：
1 资料与方法
1.1 一般资料
2008年6月~2010年6月，我校门诊采用微波和(或)清喉利咽颗粒治疗慢性肥厚性咽炎540例，随机分为3组。治疗组180例，男78例，女112例；年龄19~66岁，平均(40.4±10.2)岁；病程10个月~30年，平均(7.2±5.1)年。对照组Ⅰ180例，男84例，女96例；年龄17~64岁，平均(41.1±10.1)岁；病程1~34年，平均(7.6±5.8)年。对照组Ⅱ180例，男80例 ......
您现在查看是摘要介绍页，详见PDF附件(2167KB，2页)。